XML 96 R32.htm IDEA: XBRL DOCUMENT v3.25.0.1
SEGMENT DATA AND RELATED INFORMATION (Tables)
6 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of segment data and related information
Three Months Ended
December 31,
Six Months Ended
December 31,
(In millions)2024202320242023
PRODUCT CATEGORY DATA
Net sales:
Skin Care$1,921 $2,173 $3,450 $3,813 
Makeup1,150 1,167 2,188 2,229 
Fragrance744 737 1,374 1,373 
Hair Care159 173 298 321 
Other30 30 55 62 
4,004 4,280 7,365 7,798 
Returns associated with restructuring and other activities— (1)— (1)
Net sales$4,004 $4,279 $7,365 $7,797 
Operating income (loss) before charges associated with restructuring and other activities:
Skin Care$306 $415 $423 $452 
Makeup(211)30 (396)(10)
Fragrance(446)131 (386)238 
Hair Care(3)(3)(21)(25)
Other(45)(34)27 
(399)582 (414)682 
Reconciliation:
Charges associated with restructuring and other activities(181)(8)(287)(10)
Interest expense(90)(98)(182)(193)
Interest income and investment income, net23 40 58 81 
Other components of net periodic benefit cost(3)(5)
Earnings (loss) before income taxes$(650)$519 $(830)$565 
GEOGRAPHIC DATA(1)
Net sales:
The Americas$1,223 $1,242 $2,410 $2,450 
Europe, the Middle East & Africa1,494 1,589 2,724 2,841 
Asia/Pacific1,287 1,449 2,231 2,507 
4,004 4,280 7,365 7,798 
Returns associated with restructuring and other activities— (1)— (1)
Net sales$4,004 $4,279 $7,365 $7,797 
Operating income (loss):
The Americas$(823)$(55)$(991)$(237)
Europe, the Middle East & Africa316 379 406 523 
Asia/Pacific108 258 171 396 
(399)582 (414)682 
Charges associated with restructuring and other activities(181)(8)(287)(10)
Operating income (loss)$(580)$574 $(701)$672 
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.